A A A A
 
Pages
Our Supporters How to Participate in Precision Panc Remit of Scientific Advisory Board Meeting Minutes Membership Remit of Therapeutic Testing Board Meeting Minutes Precision Panc Therapeutic Testing Board Membership Remit of Steering Committee Patient Stories Steering Group Members Therapeutic Testing Board Meetings PRIMUS 002 PRIMUS 001 Working with the NHS Patient Public Engagement Meetings Steering Committee Scientific Advisory Board Governance Structure Governance Master Protocol Kick Off Meeting News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Research History Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Posts
Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Menu
 
 
Home | Privacy Policy
 
This site uses cookies.
 

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.

Privacy Policy

Samples from the Precision Panc clinical trials are processed at the Glasgow Precision Oncology Laboratory (GPOL).

At GPOL, we perform genetic analysis of cancer cells and normal cells. We use this information for the purposes of research: to better understand the genetic changes that cause cancer to guide the development of improved treatments.

We do not know who the samples belong to, as we do not hold names, addresses or similar information. The samples and information we have are identified by a unique code which can be linked back to you by the person in charge of the study you are taking part in. This might be your NHS doctor or a scientist who has asked you to help with their research.

We keep all your data in a secure environment which can only be accessed by relevant members of GPOL staff. We will not share your data with anyone other than the doctor or scientist in charge of the study, or one of their team. We will keep your data until the person in charge of the study is satisfied that no more analysis needs to be performed.

If you need any further information, please write to us at: Patient Enquiries, GPOL, Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, G61 1QH. Alternatively, you can email: contact@precisionpanc.org. This Privacy Notice came into effect on the 25th May 2018 and will be reviewed after 1 year.

© 2019 Precision Panc
Web design by Creatomatic